Low-Dose Cyclophosphamide Synergizes with Dendritic Cell-Based Immunotherapy in Antitumor Activity

Clinical immunotherapy trials like dendritic cell-based vaccinations are hampered by the tumor's offensive repertoire that suppresses the incoming effector cells. Regulatory T cells are instrumental in suppressing the function of cytotoxic T cells. We studied the effect of low-dose cyclophospha...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Veltman, Joris D., Lambers, Margaretha E. H., van Nimwegen, Menno, de Jong, Sanne, Hendriks, Rudi W., Hoogsteden, Henk C., Aerts, Joachim G. J. V., Hegmans, Joost P. J. J.
Format: Artigo
Langue:Inglês
Publié: Hindawi Publishing Corporation 2010
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC2874992/
https://ncbi.nlm.nih.gov/pubmed/20508851
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/798467
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires